Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002306 |
---|---|
Receipt number | R000002819 |
Scientific Title | Phase II study of amrubicin for non-small lung cancer after failure of two or three prior chemotherapy regimens |
Date of disclosure of the study information | 2009/08/07 |
Last modified on | 2012/08/07 14:30:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/08/07 02:15:25 | ||
2 | Update | 2009/12/21 19:06:37 | Recruitment status |
|
3 | Update | 2010/02/08 12:20:03 | Email1 |
|
4 | Update | 2010/08/07 12:49:59 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2011/05/18 15:24:52 | Recruitment status |
|
6 | Update | 2011/12/06 19:19:15 | Last follow-up date |
|
7 | Update | 2012/08/07 14:28:06 | Division name Division name Division name Division name Division name Division name Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Institutions |
|
8 | Update | 2012/08/07 14:30:02 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results |